Abstract
THE finding that allogeneic pig liver transplants frequently survive for a significantly prolonged period of time even without immunosuppression has led to a new line of research1,2. Calne and his colleagues have shown that the recipient of an allogeneic liver transplant showed partial tolerance towards kidney, and to a lesser extent towards skin transplants, when these were obtained from the same animal as was the liver.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Peacock, J. H., and Terblanche, J., The Liver, 333 (Butterworths, London, 1967).
Calne, R. Y., White, H. J. O., Yoffa, D. E., Maginn, R. R., Binns, R. M., Samuel, J. R., and Mollna, V. P., Brit. Med. J., 2, 478 (1967).
Calne, R. Y., Sells, R. A., Pena, J. R., Davis, D. R., Millard, P. R., Herbertson, B. M., Binns, R. M., and Davies, D. A., Nature, 223, 472 (1969).
Kissmeyer-Nielsen, F., and Kjerbye, K. E., Histocompatibility Testing, 381 (Munksgaard, Copenhagen, 1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
VAN ROOD, J., VAN LEEUWEN, A. & VAN SANTEN, M. Anti HL-A2 Inhibitor in Normal Human Serum. Nature 226, 366–367 (1970). https://doi.org/10.1038/226366a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/226366a0
- Springer Nature Limited
This article is cited by
-
Peptides Derived from a Soluble Molecule of the Human Leukocyte Antigen (HLA) Class I Cause Apoptosis in Gastric Cancer Cell Lines
Digestive Diseases and Sciences (2009)
-
Levels of soluble HLA-I and β2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy
Leukemia (2007)
-
In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand
Leukemia (2007)
-
HLA-G and its role in implantation (review)
Journal of Assisted Reproduction and Genetics (2007)
-
Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients
Rheumatology International (2005)